Deidre Johns

Deidre Johns serves as the Head of Chemistry at ArrePath since August 2024, following a role as VP of Chemistry at Rezo Therapeutics. Previously, Deidre was the Director of Medicinal Chemistry at Turning Point Therapeutics and a Principal Scientist in Medicinal Chemistry at Takeda, focusing on research related to gastrointestinal and liver diseases. Deidre's academic career includes positions as Principal Investigator and Assistant Professor at Oregon State University and a Senior Research Scientist at Eli Lilly. Earlier experience includes work at Los Alamos National Laboratory and Air Products & Chemicals. Deidre Johns earned a Ph.D. in Organic Chemistry from the University of Colorado Boulder and completed postdoctoral work funded by the American Cancer Society.